Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Amortization of Deferred Charges (2021 - 2025)

Core Scientific's Amortization of Deferred Charges history spans 5 years, with the latest figure at -$4.7 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 455.86% year-over-year to -$4.7 million; the TTM value through Sep 2025 reached $6.0 million, up 92.36%, while the annual FY2024 figure was $3.7 million, 388.83% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was -$4.7 million at Core Scientific, down from $4.7 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $6.2 million in Q4 2021 and bottomed at -$4.7 million in Q4 2025.
  • The 5-year median for Amortization of Deferred Charges is $963000.0 (2022), against an average of $1.1 million.
  • The largest YoY upside for Amortization of Deferred Charges was 20230.43% in 2025 against a maximum downside of 455.86% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $6.2 million in 2021, then crashed by 84.59% to $963000.0 in 2022, then decreased by 21.91% to $752000.0 in 2023, then skyrocketed by 74.73% to $1.3 million in 2024, then plummeted by 455.86% to -$4.7 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Amortization of Deferred Charges are -$4.7 million (Q4 2025), $4.7 million (Q3 2025), and -$1.7 million (Q2 2025).